跳至主要内容
临床试验/NCT05125822
NCT05125822招募中不适用

Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity

Ann & Robert H Lurie Children's Hospital of Chicago2 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2023年8月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
260
试验地点
2
主要终点
Change in ghrelin

研究概览

简要总结

In this study, doctors want to find out more about why people who lose weight often regain the weight that they have lost once they resume a regular diet and whether hormones might play a role in weight regain. The study is divided into two parts, called the meal replacement period and the follow-up period. The meal replacement period will consist of drinking a shake for breakfast and lunch and eating a frozen meal for dinner that is calorie controlled. Individuals will also be asked to eat two servings of fruit and three servings of vegetables each day. The study will provide the shakes and the frozen entrees, participants are asked to supply the fruits and vegetables.

Participation in this study will last for up to 35 weeks. There will be 10 in-person visits and 13 visits by phone or over Zoom over the 35 weeks.

详细描述

Individuals who are found to be eligible to participate will have two study interventions: An 8-week meal replacement therapy period in which they are asked to reduce their BMI by >5%. Participants will be asked to strictly follow the individually-prescribed eating regimen which will include meal replacement shakes and/or frozen meals to be used for breakfast and lunch. For dinner, the study will provide pre-packaged frozen entrée meals to be consumed with two servings of fruit and three servings of vegetables per day. Meal replacement compliance will be assessed by requiring participants to maintain a dietary log throughout the study. The percentage of days for which the protocol was followed (no additional calories consumed) will serve as the primary metric of compliance.

Participants will also receive a standardized lifestyle/behavioral modification counseling every 2 weeks throughout the entire study, which will be delivered at each in-person study visit and via virtual platform of phone when there is no in-person study visit scheduled. The lifestyle curriculum will incorporate evidence-based behavior change principles including dietary modification, energy expenditure modification, behavior modification and family involvement and support. To ensure fidelity and adherence to the delivery protocol, a manual will be developed for each session that trained staff will follow when administering the curriculum.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
11 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 11 to less than 16 years old
  • BMI > 30 kg/m^2 or 95th BMI percentile
  • Tanner stage 2, 3, or 4

排除标准

  • Tanner stage 1 and 5
  • Prior bariatric surgery
  • Current or recent (< 3 months prior to enrollment) use of anti-obesity medication(s) defined as orlistat, metformin, phentermine, topiramate, combination phentermine/topiramate, liraglutide, and/or combination naltrexone/bupropion (monotherapy use of naltrexone or bupropion is not an exclusion)
  • Monogenic and hypothalamic obesity
  • Polycystic ovary syndrome (diagnosed by a physician)
  • Pregnancy or planned pregnancy
  • Current use of supplemental hormones
  • Individuals with a diagnosed eating disorder of anorexia nervosa, bulimia or binge eating disorder
  • Type 1 or 2 diabetes
  • Treatment with growth hormones
  • Thyroid disease/problem
  • Has had cancer in the last 10 years

研究组 & 干预措施

Meal Replacement and Lifestyle Therapy

Experimental

Participants in this study will have an 8-week meal replacement therapy period in which they are asked to reduce their BMI by 5% by following a prescribed eating regimen consisting of meal replacement shakes and/or frozen meals for breakfast and lunch. For dinner they will consume a pre-packaged frozen entree to be consumed with two servings of fruit and three servings of vegetables per day. Participants will also have lifestyle/behavioral modification counseling every 2 weeks throughout the entire study.

干预措施: Meal replacement and lifestyle modification (Other)

结局指标

主要结局

Change in ghrelin

时间窗: 17 weeks.

We hypothesize that after the initial weight loss with MRT that we will see an increase in the level of the appetite regulating hormone ghrelin.

Change in gastric inhibitory polypeptide

时间窗: 17 weeks

We hypothesize that after the initial weight loss with MRT that we will see an increase in the level of the appetite regulating hormone gastric inhibitory polypeptide.

Change in fat mass regain after initial weight loss with meal replacement therapy (MRT)

时间窗: 17 weeks.

We hypothesize that the greater the initial weight loss with MRT the greater the fat mass regain at 26 weeks.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Justin Ryder

Vice Chair of Research for the Department of Surgery at Lurie Children's Hospital

Ann & Robert H Lurie Children's Hospital of Chicago

研究点 (2)

Loading locations...

相似试验